David C. Gale
Plus aucun poste en cours
Historique de carrière de David C. Gale
Anciens postes connus de David C. Gale
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| INTERSECT ENT, INC. | Directeur Technique/Scientifique/R&D | 01/01/2007 | 01/08/2009 |
| ARTIVION, INC. | Directeur Technique/Scientifique/R&D | 06/01/2012 | - |
Formation de David C. Gale
| The University of Alabama | Doctorate Degree |
| Auburn University | Graduate Degree |
| The University of Manchester | Graduate Degree |
Statistiques
Internationale
| Etats-Unis | 5 |
| Royaume-Uni | 2 |
Opérationnelle
| Chief Tech/Sci/R&D Officer | 2 |
| Graduate Degree | 2 |
| Doctorate Degree | 1 |
Sectorielle
| Consumer Services | 4 |
| Health Technology | 2 |
| Health Services | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| ARTIVION, INC. | Health Technology |
| Entreprise privées | 1 |
|---|---|
Intersect ENT, Inc.
 Intersect ENT, Inc. Medical/Nursing ServicesHealth Services Intersect ENT, Inc. is a commercial drug delivery company, which engages in the treatment of ear, nose, and throat conditions. Its products include PROPEL and SINUVA. The PROPEL used to maintain the opening and locally deliver steroid after sinus surgery. The SINUVA is used to treat adult patients with ethmoid sinus surgery yet suffer from recurrent sinus obstruction due to polyps. The company was founded by Donald J. Eaton in October 2003 and is headquartered in Menlo Park, CA. | Health Services |
- Bourse
- Insiders
- David C. Gale
- Expérience
